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Abstract
Background: ADAM11 is a member of the ADAM gene family and is mainly expressed in the
nervous system. It is thought to be an adhesion molecule, since it has a disintegrin-like domain
related to cell-cell or cell-matrix interactions. To elucidate the physiological functions of ADAM11,
we generated ADAM11-deficient mice by means of gene targeting.
Results: ADAM11-deficient mice were apparently normal, and survived more than one year with
no major histological abnormalities in the brain or spinal cord. Because ADAM11 is highly
expressed in the hippocampus and cerebellum, we have examined ADAM11 mutant mice for
learning using visual and hidden water maze tasks, and their motor coordination using a rotating
rod task. Our results showed that their visual water maze task results are normal, but the hidden
water maze and rotating rod task skills are impaired in ADAM11-deficient mice.
Conclusion: Our results indicate that ADAM11 mutation does not affect cell migration and
differentiation during development, but affects learning and motor coordination. Thus, ADAM11
might play an important signalling or structural role as a cell adhesion molecule at the synapse, and
may thus participate in synaptic regulation underlying behavioural changes.
Background
The ADAM (A Disintegrin And Metalloprotease) family
comprises membrane-spanning multi-domain proteins
containing a metalloproteinase-like domain and a disin-
tegrin-like domain. Approximately half of the ADAMs are
catalytically active metalloproteases that shed a broad
range of substrates, such as cytokines, growth factors,
receptors, adhesion molecules [1,2]. Recent gene-disrup-
tion studies in mice have disclosed a physiological role of
each ADAM. For example, ADAM10, ADAM17 and
ADAM19 are critical for normal development by provid-
ing growth signals at the correct times and places [3-6]. In
contrast, the functions of ADAM8, ADAM9, ADAM12 and
ADAM15 are not essential for embryogenesis, suggesting
a possible functional redundancy with other protease [7-
10]. The remaining half, which are non-protease-ADAMs,
are thought to be adhesion molecules. More than ten
ADAMs have been shown to support integrin-mediated
cell adhesion in vitro [11]. More recently, the finding has
been reported that integrin-mediated cell migration of tis-
sue culture cells can be controlled by distinct ADAMs [12].
In C. elegans, unc-71 gene coding a non-protease-ADAM
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Targeted mutation of Adam11 Figure 1
Targeted mutation of Adam11. (A) Top; Domain structure of ADAM11 protein. PRO, proprotein; MP, metalloprotease-
like; DIS, disintegrin-like; CR/EGF, Cysteine-rich and EGF-like repeat; TM, transmembrane; Cyto, cytoplasmic domain. Adam11 
gene was disrupted by the insertion of a termination codon and a PGKneo cassette into exons 5 – 7. An MC1/TK cassette at 
the end of the targeting vector allowed for negative selection. The BE2K-probe used for Southern blot analysis, and the 
expected BamHI "B" fragments of the targeted allele (TG) and wild-type allele (WT) are indicated by arrows. The primers, 
AGN1 and 033 were used for the selection of the recombinant ES clones. (B) Southern blot analysis of mouse genomic DNA. 
The expected DNA fragments for the wild-type allele (WT) and targeted allele (TG) are 13.7-kb and 10.3-kb, respectively. +/+, 
wild-type; +/-, heterozygote; -/-, homozygote. (C) Western blot analysis of ADAM11 expression in the mouse cerebellum. 
Absence of ADAM11 protein in the (-/-) mutant cerebellum was shown using anti-ADAM11 monoclonal antibody. "P" indicates 
the positive control, HA-tagged mouse ADAM11 protein expressed in HeLa cells. White circle indicates mature-form of 
ADAM11 protein and black circle shows immature-form, which was not processed. (D) Hippocampus sections with HE stain. 
Scar = 30 μm. (E) Cerebellum sections with HE stain. Scar = 200 μm.
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protein have been shown to be involved in cell migration
events in vivo [13]. However, the physiological roles of
mammalian non-protease-ADAMs are poorly understood
in vivo. Genetic deletion studies in mice have shown that
both Adam2-null and Adam3-null male mutants are infer-
tile and their spermatozoa lack egg-binding abilities [14-
16]. The precise mechanism is under investigation [17].
We have reported the findings of ADAM11, ADAM22 and
ADAM23 genes and their restricted expression in the
human and murine nervous systems [18,19]. These
ADAMs lack a catalytic motif critical for the metalloprotei-
nase activity, suggesting that they are not proteases. We
assume that these ADAMs might contribute to cell migra-
tion, differentiation and survival or synaptic regulation by
binding to integrins, cell-surface proteins or intracellular
signalling molecules [20,21]. We have reported severe
ataxia, seizures, and death before weaning, accompanied
with hypomyelination of the peripheral nervous system in
Adam22-null mutant mice [22]. It has been reported that
the disruption of Adam23 gene in the mouse results in pre-
mature death associated with ataxia and tremor [23]. Is
spite of such extreme phenotypes, no histological defects
in the brain has been observed in either Adam22-null nor
Adam23-null mice.
ADAM11 is the closest paralog of ADAM22 and ADAM23,
and its orthologs have been found in vertebrates, but not
in invertebrates. It has been reported that the Xenopus
ADAM11 ortholog, xMDC11a, has an expression pattern
associated with neural development, with a proposed role
in cell migration [24]; and it has been reported in analyses
using Northern blot and in situ hybridisation methods
that the murine Adam11 gene is expressed in both the
developing and adult nervous system [19,25]. These find-
ings led us to hypothesise that ADAM11 is an integrin
binder that plays an important role in the nervous system,
as do ADAM22 and ADAM23. To determine the physio-
logical functions of ADAM11, we generated and analysed
Adam11 gene-targeted mice.
Results
Generation of ADAM11-deficient mice
Mice carrying a targeted mutation in their Adam11 gene
were generated by homologous recombination (Fig. 1A).
Correct targeting events were confirmed by Southern blot
analysis (Fig. 1B). As a result of this procedure, since a ter-
mination codon was introduced in exon 5 in the pro-pro-
tein domain, only the truncated form of the ADAM11
protein would be synthesised from this targeted allele.
Because pro-protein domains are always removed in
mature functional ADAM-proteins by furin-like proteases
and are thus thought to be non-functional, we concluded
that this truncated form of ADAM11 protein would have
no function [26]. Absence of mature ADAM11 protein in
homozygous mutants was confirmed by Western blot
analysis using a specific antibody that recognises the
ADAM11 protein (Fig. 1C). Analysis by Western blot
showed that heterozygous mutants produced approxi-
mately half of the wild-type levels of ADAM11 protein.
ADAM11-deficient mice are viable and appear normal
Mating of mice heterozygous for the ADAM11 mutation
yielded a near-Mendelian distribution of genotypes in the
offspring and the ratio of females and males was the same
in all groups (data not shown). For the present experi-
ments, ADAM11-deficient male mice (backcrossed gener-
ations into C57BL/6NCrj, n = 14) were used in all
behavioural analyses and anatomical-histological studies.
Homozygous ADAM11-deficient mice were viable and
appeared normal, indicating that the Adam11 gene is not
essential to development and survival. The gain in body
weight of (-/-) mice was comparable to that of (+/+) and
(+/-) mice at least until 24 weeks of age (data not shown).
There was no significant difference in locomotor activity
among (+/+), (+/-) and (-/-) genotypes (data not shown).
No apparent anatomical-histological change was
observed in the spinal cord, heart, lung, liver, kidney,
spleen, testis or ovary (data not shown). The brain of (-/-
) mice, including the hippocampus (Fig. 1D) and cerebel-
lum (Fig. 1E) appeared normal after HE staining when (+/
+), (+/-) and (-/-) mice were compared. Since Adam11 is
predominantly expressed in the hippocampus and cere-
bellum, we applied hippocampus- or cerebellum-depend-
ent behavioural analyses.
Spatial learning in ADAM11-deficient mice
To study the functions of ADAM11 in the hippocampus,
we examined the spatial learning ability of ADAM11-defi-
cient mice using the Morris Water Maze task [27]. First,
mice were trained in a hidden platform task, in which
mice searched for a submerged platform to escape from
the water. Adam11 (-/-) mice were found to take a signifi-
cantly longer time to locate the hidden platform than (+/
+) and (+/-) mice (Fig. 2A). Nonetheless, the ability of (+/
+), (+/-) and (-/-) mice to find the hidden platform
improved over test sessions (Fig. 2A). Thus, (+/+), (+/-)
and (-/-) mice were able to learn the location of the hid-
den platform during the course of the trials, although the
capacity of (-/-) mice to find the platform was lower than
that of (+/+) and (+/-) mice. We further performed a
probe test, in which the platform was removed from the
pool after completion of the hidden platform task, and
the trained mice were allowed to swim freely for 60 sec.
The time spent in the target quadrant of (-/-) is signifi-
cantly lower than that of (+/+) mice (Fig. 2B). Adam11 (+/
-) mice appeared to spend a shorter time in the target
quadrant, but there was no significant difference between
(+/+) and (+/-) mice (Fig. 2B). These results indicate a spa-
tial learning impairment in (-/-) mice. The swimming dis-BMC Neuroscience 2006, 7:19 http://www.biomedcentral.com/1471-2202/7/19
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Morris water maze task of ADAM11-deficient mice Figure 2
Morris water maze task of ADAM11-deficient mice. (A) Escape latencies (sec) in the hidden platform task over nine 
testing days. Asterisk: significant (p < 0.05) difference from (+/+) mice. (B) The probe test after the acquisition trials of the hid-
den platform task. Times spent in each quadrant of the water pool are shown. Asterisk: significant (p < 0.05) difference from 
(+/+) mice. TQ, training quadrant; AR, adjacent right quadrant; AL, adjacent left quadrant; OP, opposite quadrant. (C) Swim-
ming distances (cm) during the probe test. (D) Escape latencies (sec) in the visible platform task over three testing days. +/+, +/
- and -/-; n = 11, 14 and 12, respectively.
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tance of (+/+), (+/-) and (-/-) mice, however, was similar
during the probe trial (Fig. 2C). In the visible platform
task, the performance of mice with (+/+), (+/-) and (-/-)
genotypes improved during the course of the test sessions,
as indicated by a progressive decrease in the latency for
locating the platform (Fig. 2D), suggesting that (-/-) mice
learn this visible platform task just as well as (+/+) and (+/
-) mice. These results also indicated that (-/-) mice have
normal visible and motor function and the motivation
needed in the water maze task.
Motor function of ADAM11-deficient mice
To study the functions of ADAM11 in the cerebellum, we
examined the motor function of ADAM11-deficient mice
Retention time of ADAM11-deficient mice on the rotating rod at speeds of 0 rpm (stationary), 5, 10 and 15 rpm Figure 3
Retention time of ADAM11-deficient mice on the rotating rod at speeds of 0 rpm (stationary), 5, 10 and 15 
rpm. Asterisk: significant (p < 0.05) difference from (+/+) mice. +/+, +/- and -/-; n = 11, 14 and 12, respectively.
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using a rotating rod task [28]. In the rotating rod test, the
retention time of (+/-) and (-/-) mice on the rod was not
significantly different from that of (+/+) mice at 0 rpm
(stationary) [+/-: F (1, 80) = 1.67, p = 0.21; -/-: F (1, 88) =
0.002, p = 0.96] (Fig. 3A). In (+/-) mice, the tendency of
decreased retention times was seen at 5, 10 and 15 rpm,
but there was no significant difference between (+/+) and
(+/-) mice [5 rpm: F (1, 20) = 1.27, p = 0.27; 10 rpm: F (1,
20) = 1.07, p = 0.31; 15 rpm: F (1, 20) = 2.716, p = 0.11]
(Figs. 3B, 3C and 3D). However, (-/-) mice fell more
quickly from the rod than (+/+) mice at 5, 10 and 15 rpm
[5 rpm: F (1, 27.3) = 17.51, p = 0.0002; 10 rpm: F (1, 22)
= 11.05, p = 0.003; 15 rpm: F (1, 22) = 19.22, p = 0.0002]
(Figs. 3B, 3C and 3D). The retention time was not signifi-
cantly improved in (-/-) mice across trials of training at 5,
10 and 15 rpm [5 rpm: F (3, 15.3) = 2.05, p = 0.15; 10
rpm: F (7, 11) = 2.61, p = 0.07; 15 rpm: F (19, 26.6) =
1.57, p = 0.14] (Figs. 3B, 3C and 3D). In a traction test, (-
/-) mice showed a high grip strength similar to that of (+/
+) and (+/-) mice (Fig. 4). The hanging score and time of
(-/-) mice were also similar to those of (+/+) and (+/-)
mice (Figs. 5A and 5B). A footprint test did not reveal any
abnormalities in walking patterns, including stride length
and step width, as a function of genotypes (Figs. 6A and
6B).
Discussion
In the present study, we examined the function of
ADAM11 by generating mice that lacked the Adam11
gene. It has been reported that the Adam11  gene is
expressed in the brain, heart, liver and testis, as mani-
fested in Northern blot analysis [19]. Interestingly,
ADAM11-deficient mice appeared normal and survived
more than one year without apparent histological abnor-
mality, including the brain, heart, liver and testis. The
expression patterns of the Adam11 gene in the brain have
been studied using in situ hybridisation [25]. This study
has shown high expression of ADAM11 mRNA in the hip-
pocampus and cerebellum. We therefore focused on
examining the hippocampus- and cerebellum-dependent
behavioural tests to study the functions of ADAM11 in the
nervous system.
It is widely accepted that the hippocampus is involved in
the performance of the hidden platform version of the
water maze test, since lesions of the hippocampal path-
ways lead to a severe impairment of learning in this task
[29]. In the hidden platform task, ADAM11-deficient
mice needed more time to reach the platform than wild-
type mice. Spatial learning was also assessed using a probe
trial, in which the platform was removed from the pool on
the day following nine days of training. The wild-type
mice spent significantly more time searching for the plat-
form in the target quadrant than the other quadrants.
However, ADAM11-deficient mice did not search selec-
tively in the target quadrant. On the other hand, in the vis-
ible platform version, in which the motor ability and
visual acuity of the mouse are tested, ADAM11-defieient
mice were normal. These results indicated that ADAM11-
deficient mice showed a spatial learning impairment.
The cerebellum is in charge of the smooth coordination of
somatic motor activity, regulation of muscle tone, and
mechanisms that influence and maintain equilibrium
[30]. It is widely accepted that the cerebellum is involved
in the performance of the rotating rod task, since mice
with structural abnormalities in the cerebellum [31] or
with disruptions in genes enriched in the cerebellum [32]
exhibit performance deficits in this task. In the rotating
rod test in this study, although the retention time of
ADAM11-deficient mice on the rod was not different from
wild-type mice at 0 rpm (stationary), ADAM11-deficient
mice fell more quickly from the rod than wild-type mice
at 5, 10 and 15 rpm. These results indicate that ADAM11-
deficient mice have a deficit in motor coordination. On
the other hand, in the visual platform version of the water
maze task, motor ability for swimming in ADAM11-defi-
cient mice was normal. These results suggested that there
might be a different mechanism of motor function
between swimming and the rotating rod task. It has been
also reported that the cerebellum is involved in another
important distinct function: learning associated with
component movement (motor learning) [33]. The reten-
tion time of synaptotagmin (Syt) IV-deficient mice on the
rod was significantly shorter than wild-type mice, and
they improved it approximately to the same rates as did
wild-type mice during rotating rod performance [34].
These data suggest the basis for the performance deficit on
the rotating rod task in the Syt IV mutants is in motor
Traction test (g) of ADAM11-deficient mice Figure 4
Traction test (g) of ADAM11-deficient mice. +/+, +/- 
and -/-; n = 12, 10 and 12, respectively.
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coordination rather than in motor learning. The results in
the present study showed that ADAM11-deficient mice
slightly, though not significantly, improved motor learn-
ing ability during rotating rod performance. However, the
deficit of motor learning in ADAM11-deficient mice was
not clear in this study. Because they could not ride on the
rotating rod, they might not learn this task. To examine
motor learning ability in ADAM11-deficient mice in
detail, we will need to use other cerebellar-dependent
learning tasks, such as a classical eyelid conditioning test.
There was no impairment in the grip strength and wire
suspension test in ADAM11-deficient mice. Spontaneous
motor activity and walking patterns of ADAM11-deficient
mice were also found to be normal, suggesting that the
dysfunction found in the rotating rod test was not derived
from muscle weakness or other peripheral disturbances.
These results suggest that limited brain sites, mainly the
hippocampus and cerebellum, might contribute to the
dominant phenotype, spatial learning impairment and
motor discoordination in ADAM11-deficient mice. In situ
hybridisation analysis has detected Adam11 gene expres-
sion in the pyramidal cells of CA1–CA3 fields and granule
cells of the dentate gyrus in the hippocampus and in gran-
ular cells in the cerebellum [25]. It is unlikely that mor-
phological changes during development led to
impairment of spatial learning and motor coordination,
and morphological alterations in the cytoarchitecture of
the hippocampus and cerebellum were not observed in
ADAM11-deficient mice after histological investigation
using HE staining. However, because it is thought that
ADAM11 plays a role in neuron-neuron or neuron-glial
cell interactions, a more precise morphological investiga-
tion will be needed. It has been reported that adhesion
molecules, such as neural cell adhesion molecule
(NCAM), are not only implicated in cell interactions dur-
ing nervous system development, but are also recognised
as important mediators of synaptic plasticity in the adult
nervous system [35]. Changes in neuron excitability in the
hippocampus, such as decreases in the post-burst after
hyperpolarization (AHP), have been thought to affect
long-term potentiation (LTP) [36], an experimental
model of the synaptic changes thought to underlie learn-
ing and memory [37]. It has also been reported that mice
lacking NMDA receptor for both NR2A and NR2C subu-
nits showed motor dysfunction and complete loss of both
spontaneous and evoked excitatory postsynaptic currents
(EPSCs) in cerebellar granule cells [38]. Therefore, electro-
phyological studies to enable analysis of synaptic trans-
mission and plasticity in the hippocampus and
cerebellum of ADAM11-deficient mice will be needed.
These studies might clarify whether ADAM11 plays an
important signalling or structural role at the synaptic level
and whether it participates in synaptic regulation.
Wire suspension test of ADAM11-deficient mice Figure 5
Wire suspension test of ADAM11-deficient mice. (A) Score in the wire suspension test. (B) Retention time (sec) in the 
wire suspension test. +/+, +/- and -/-; n = 12, 10 and 12, respectively.
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ADAM11-deficient mice remained alive for more than
one year without ataxia or tremor, but showed a deficit in
spatial learning and motor dysfunction. On the other
hand, mice lacking the Adam22  gene showed severe
ataxia, exhibited marked hypomyelination of the periph-
eral nerves, and died before weaning [22]. Mice lacking
the Adam23 gene showed severe ataxia and tremor and
died before weaning [23]. These findings suggest that
ADAM11, ADAM22 and ADAM23 have separate and
important roles in the nervous system. A genome database
search revealed orthologs of ADAM11, ADAM22 and
ADAM23 genes to exist in vertebrates such as mammals,
fish, and amphibians, but not in invertebrates. Although
the precise molecular functions of these ADAMs are still
unclear, further investigations will provide clues to under-
standing the nervous system of higher organisms.
Conclusion
ADAM11-deficient mice survived more than one year
without ataxia or tremor, showed no abnormalities in
body weight gain, spontaneous motor activity, muscle
strength, or walking patterns, and exhibited no apparent
anatomical-histological changes. However, hippocam-
pus-dependent spatial learning and cerebellum-depend-
ent motor coordination in ADAM11-deficient mice were
impaired when tested using water maze and rotating rod
tasks. Our genetically modified mouse strain has the
potential to be a useful and sensitive tools for detailed
investigation of ADAM proteins' functions in the nervous
system.
Methods
Construction of an Adam11 gene-targeting vector
The 13.7-kb BamHI DNA fragment covering exons 2 – 20
of the Adam11  gene was amplified from C57BL/6
genomic DNA by the PCR using Expand Hi-Fidelity
polymerase mix (Roche Diagnostics KK, Tokyo, Japan). To
generate a mutation in the mouse Adam11  gene, we
inserted a PGKneo cassette into exons 5 – 7 of the Adam11
gene. The final targeting construct consisted of a 10.1-kb
genomic DNA fragment that was interrupted by the inser-
tion of the PGKneo cassette and contained a MC1/TK cas-
sette as a negative selection marker against random
integration [39].
Generation of Adam11 deficient mice
The linearised targeting vector was electroporated into
TT2 embryonic stem (ES) cells [40]. Homologous recom-
binants were selected by PCR using the following primers,
AGN1: 5'-TCGTGCTTTACGGTATCGCCGCTCCCGATT-3'
in the PGKneo cassette, and SGN033: 5'-GGACCCGGAA-
GACATTTGCACGGT-3' outside the targeting vector.
Homologous recombined DNA was efficiently amplified
by 35 cycles of the following amplification steps (94°C-
30 sec and 68°C-5 min). Correctly targeted ES clones were
injected into fertilised ICR mouse eggs at the eight-cell
Footprint test of ADAM11-deficient mice Figure 6
Footprint test of ADAM11-deficient mice. (A) Stride length (cm) in the footprint test. (B) Step width (cm) in the foot-
print test. +/+, +/- and -/-; n = 12, 10 and 12, respectively.
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stage. The resulting male chimeras were mated with
C57BL/6NCrj females (Charles River Japan, Tokyo,
Japan), and resulting heterozygous (+/-) male and female
mice were interbred to generate homozygous (-/-) mice.
Southern blot analysis
Mouse genomic DNA used for Southern blot analysis was
extracted from the liver of each genotype. BamHI-digested
genomic DNA was probed with the [32P]-labelled BE2K
probe, which was a 2.0-kb BamHI – EcoRI genomic frag-
ment located in intron 2.
Western blot analysis
The absence of ADAM11 protein in the (-/-) mice was con-
firmed by Western blot analysis. To be brief, the cerebel-
lum was isolated from a six month-old mouse of each
genotype and homogenised in cell lysis buffer (50 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 1% NP-40, protease
inhibitor cocktail [Roche Diagnostics]). After removal of
cell debris by centrifugation, the glycosylated proteins in
the supernatant were concentrated by the affinity chroma-
tography using Con A Sepharose 4B (Amersham Bio-
sciences Corp.). Each sample was separated on 10% SDS-
PAGE, and transferred to a PVDF membrane. The blot was
then incubated with monoclonal antibody against the
ADAM11 (U. S. Patent 5,631,351) at 1 μg/ml. Bound anti-
bodies were visualised with horseradish peroxidase-
labelled second antibody and an ECL-plus chemilumines-
cence detection system (Amersham Biosciences Corp.).
Behavioural analysis
All animal procedures conformed to the Japanese regula-
tions on animal care and use, following the Guideline for
Animal Experimentation of the Japanese Association for
Laboratory of Animal Science, and were approved by the
Animal Care and Use Committee of Eisai Co., Ltd. For the
present experiments, ADAM11-deficient male mice (back-
crossed generations into C57BL/6NCrj, n = 14) were used
in all behavioural analyses (22–24 weeks of age). All of
the behavioural studies were conducted between 10:00
and 16:00 by a well-trained experimenter blind to the
mouse genotypes.
Spontaneous motor activity
Locomotor activity in a novel environment was measured
by introducing mice (+/+, +/- and -/-; n = 8, 8 and 8,
respectively) for 90 min in a Plexiglas box (30 × 20 × 13
cm) using a VERSAMAX equipment and software (Accus-
can, Columbus, OH, USA).
Water maze task
Spatial learning was assessed by three variants of the Mor-
ris water maze task [27] adapted for mice. Hidden platform
task: The pool was divided into four quadrants with four
starting locations, called north, east, south and west, at
equal distances to the rim. A circular, transparent acrylic
platform (diameter 8 cm) was submerged 1 cm below the
surface of the water in the centre of the southeast quadrant
for each trial of this task. Each mouse was allowed to swim
for 60 sec and the time required to reach the platform
(escape latency) was recorded in each trial. In total this
task consisted of four trials per day over 9 days (1 min
inter-trial intervals). Each trial was initiated by randomly
placing an animal in one of the four starting locations.
Probe trial: A single probe trial was carried out after the
hidden platform task had been completed. In this trial,
the platform was removed and the movement of each
mouse was monitored using a computer-based video
tracking system (BTA-2; Muromachi Kikai Co., Ltd.,
Tokyo, Japan). Each mouse was placed into the northwest
quadrant of the pool and allowed to swim for 60 sec.
Swim path length and the time spent in the trained
(southeast) quadrant were calculated. Visible platform task:
In this task, the circular platform was made visible by
attaching a black board to it and the mouse was required
to locate the visible platform. The mouse was allowed to
swim for 60 sec and this task consisted of four trials per
day for three consecutive days (1 min inter-trial intervals).
Each trial was initiated by randomly placing an animal in
one of the four starting locations.
Rotating rod test
Motor coordination was assessed with a rotating rod
apparatus (KN-75, Natsume Seisakujo, Tokyo, Japan),
which consisted of a plastic rod (3 cm diameter, 8 cm
long) with a gritted surface flanked by two large discs (40
cm diameter). The mice were first placed on the stationary
rod for 4 successive trials, followed by 4 trials at a rotation
speed of 5 rpm, 8 trials at 10 rpm, and 20 trials at 15 rpm
in that order. Latency until a fall occurred was monitored
for 120 sec. Intra-trial intervals for each animal were more
than 20 min.
Traction test
The grip strength of each mouse was measured with a trac-
tion apparatus (FU-1, Muromachi Kikai Co., Ltd.). Each
mouse was made to grasp the attached bar (2 mm diame-
ter) with the forepaws and was slowly pulled back by the
tail. The maximum tension before release was recorded.
Wire suspension test
A mouse was placed on a stainless bar (50 cm length, 2
mm diameter, elevated up to 37 cm from a surface) at a
point midway between the supports and observed for 30
sec in four separate trials. The amount of time spent hang-
ing was recorded and scored according to the following
system [41]: 0, fell off; 1, hung onto the bar with two fore-
paws; 2, in addition to 1, attempted to climb onto the bar;
3, hung onto the bar with two forepaws and one or both
hind paws; 4, hung onto the bar with all four paws withBMC Neuroscience 2006, 7:19 http://www.biomedcentral.com/1471-2202/7/19
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tail wrapped around the bar; 5, escaped to one of the sup-
ports.
Footprint test
Black ink was applied to the hind paws of each mouse and
the mice were placed in a narrow alley (9 × 25 × 10 cm)
on white paper. Stride length and step width were calcu-
lated.
Statistics
Data are expressed as the means ± SEM. Statistical analysis
was conducted using the software package SAS 8.1 (SAS
Institute Japan Ltd., Tokyo, Japan). Statistical significance
was determined by analysis of variance (ANOVA) fol-
lowed by the Dunnett-type multiple comparison test, and
p values of less than 0.05 were considered to be significant
in the water maze task. Behavioural data in the rotating
rod test were analysed by one- or two-way ANOVA with
repeated measures, and p values of less than 0.05 were
considered to be significant.
Histopathology
Sections of tissues including the brain, spinal cord, heart,
lung, liver, kidney, spleen and testis from mice (+/+, +/-
and -/-; n = 7, 7 and 7, respectively) were fixed in 10%
buffered formalin and embedded in paraffin. Each paraf-
fin section of thick 4 μm was stained with hematoxylin
and eosin (HE).
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